Showing results (81-90 of 660) with videos related to

Sort By:
Pageof 66
The Journal of Urology|October 22, 2008
Health related quality of life in patients treated with multimodal therapy for prostate cancerAlex K Wu, Matthew R Cooperberg, Natalia Sadetsky, et al.
The Urologic Clinics of North America|May 9, 2003
Imaging clinically localized prostate cancerRajveer S Purohit, Katsuto Shinohara, Maxwell V Meng, et al.
Magnetic Resonance Imaging|January 14, 2023
Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standardMatthew Gibbons, Jeffry P Simko, Peter R Carroll, et al.
The Journal of Urology|January 22, 2008
The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitorsIrwin H Lee, Natalia Sadetsky, Peter R Carroll, et al.
Obstetrics and Gynecology|October 2, 2004
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluationDeborah Grady, Bruce Ettinger, Elena Moscarelli, et al.
Menopause (New York, N.Y.)|August 12, 2015
Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trialAlison J Huang, Steven R Cummings, Michael Schembri, et al.
The Journal of Urology|November 17, 2009
The impact of male circumcision on HIV transmissionSean M Doyle, James G Kahn, Nap Hosang, et al.
Cancer|May 23, 2007
Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURECharles J Ryan, Eric P Elkin, Janet Cowan, et al.
The American Journal of Medicine|May 25, 2011
Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studiesElaine W Yu, Scott R Bauer, Paul A Bain, et al.
Obstetrics and Gynecology|April 2, 2005
Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiolSusan R Johnson, Bruce Ettinger, Judith L Macer, et al.
Pageof 66